Pancreas transplant is the only method that enables diabetic patients to have a normal carbohydrate metabolism in the long-term. Its application in selected patients has shown to have patient survival rates, at one year of the graft, similar to those transplanted with other solid organs, such as kidney, heart, liver, etc. The indications are currently well established, with combined pancreas-kidney transplant being the most common, followed by pancreas transplant after a functioning kidney transplant and isolated pancreas transplant in pre-uraemic patients. In 2005, in Spain, under the auspices of the National Transplant Organisation (ONT), a consensus meeting was held with the scientific societies involved in this type of transplant, to standardise its indications and highlight its benefits in order to optimise the results of this transplant in our country. The most important conclusions of this consensus meeting are discussed in this short article.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ciresp.2009.06.016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!